HIGHLIGHTS
- who: Drenka Trivanoviu0107 et al. from the IZKF Group Tissue Regeneration in Musculoskeletal Diseases, University Hospital Wuerzburg, Wuerzburg, Germany have published the article: Editorial Mediators of Inflammation in Bone Physiology and Diseases, in the Journal: Mediators of Inflammation of 19/03/2022
- what: Since osteonecrosis is clinical complication of sickle cell disease, in this study, T_cells were analyzed in human peripheral blood and bone marrow aspirates of healthy and sickle cell disease patients. This study reported a reduced potential of tantalum nanoparticles to induce TNFu03b1 and IL1u03b2 as well as reactive oxygen species by macrophages . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.